Smiths Group PLC
19 July 2005
News Release
London, 19/07/2005
For immediate release
Smiths Heimann Biometrics and Cross Match Technologies to join forces
Smiths Group plc announced today that it intends to combine Smiths Heimann
Biometrics GmbH ('SHB') with Florida-based biometrics business Cross Match
Technologies Inc. ('Cross Match'). SHB was acquired in 2002 as a part of the
larger Heimann Systems acquisition. The value of SHB's net assets being
contributed is £7 million (€11 million), yielding Smiths an approximate 40%
shareholding in the enlarged Cross Match. SHB's unaudited sales for the 12
months to June 2005 were £13 million (€19 million). The transaction is expected
to be completed in early August 2005.
SHB and Cross Match supply complementary products and services that enable the
reading, storage and recognition of biometric data: capabilities which are
increasingly required by both law enforcement agencies and civil authorities.
The increased geographical spread of the combined business will ensure that its
complete product range is available in all the key markets around the world.
About Smiths Group & Smiths Detection
Smiths Group designs and manufactures safety-critical systems and products, and
has market leading positions in aerospace, detection systems, medical devices,
mechanical seals and interconnect products. For further information visit
www.smiths-group.com
Smiths Detection offers technologically advanced security solutions to detect
and identify explosives, chemical & biological agents, weapons and contraband.
Employing trace detection technology together with Smiths Heimann x-ray imaging,
Smiths Detection provides screening solutions for customers in civil and
military markets worldwide
- Ends -
Contacts:
Media: Investors:
Chris Fox Russell Plumley
+44 (0) 20 8457 8403 +44 (0) 20 8457 8203
chris.fox@smiths-group.com russell.plumley@smiths-group.com
Notes to Editors
About Smiths Heimann Biometrics
Smiths Heimann Biometrics GmbH was acquired by the Smiths Group as a small part
of the larger Heimann Systems GmbH acquisition in 2002. SHB entered the
biometrics business in 1996 and is based in Jena, Germany. It designs and
manufactures optical scanners for biometric imaging, for example of finger and
palm prints, and its products are widely used by law enforcement agencies. It
has approximately 90 employees, the majority in Jena with some salespeople in
Las Vegas, USA.
About Cross Match
Cross Match was established in 1996 in Palm Beach Gardens, Florida, USA. With
160 employees, its optical scanners for the digital capture of finger and palm
prints are widely used for identification by the military and by civil
authorities in the USA.
About the combined company
The combined company will be able to supply an enhanced range of products, for
example:
• SHB produced the first 10-fingerprint flat capture product for civilian
background checks approved by the US Federal Bureau of Investigation.
• SHB's combined palm printer and 10-fingerprint system is one of the
most successful systems in the industry and is meeting customer needs with
approximately 4500 installations.
• SHB's newly released 'Authenticator' reads ID cards and other
documents, captures biometric data and hence confirms identity.
• The US Department of Defense and the FBI are using the Cross Match
fingerprint and multimode biometric readers in the harshest areas of the
world.
• Cross Match recently released the first in a series of identity
management solutions, the VisTrakTM, for visitor and inmate tracking.
• Cross Match's award winning ID 500TM fingerprint capture system was
designed to meet the needs of both civil authorities and the emerging
commercial market. The system has been purchased by over 100 financial
institutions for employee background checks.
• Cross Match also provides fingerprint background check services through
a national network of medical centres.
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.